Skin cells could help discover cause of Parkinson's disease

July 14, 2010

Researchers are applying new stem cell technology to use skin samples to grow the brain cells thought to be responsible for the onset of Parkinson's disease, the UK National Stem Cell Network (UKNSCN) annual science meeting will hear today.

Dr Richard Wade-Martins, head of the Oxford Centre, will explain how he and his team will be gathering data from over 1,000 patients with early stage Parkinson's disease and taking small samples of skin tissue to grow special stem cells - induced (iPS cells). iPS cells can be generated from accessible tissue such as the skin and then used to generate specific types of cell.

The researchers will use the iPS cells to grow - the responsible for the production of dopamine, as it is these cells which die in patients with Parkinson's, leading to the onset of the disease.

Dr Wade-Martins explains: "Parkinson's disease is the second most common neurodegenerative disease in the UK and is set to become increasingly common as we live longer. iPS cells provide new and exciting opportunities to grow and study dopamine neurons from patients for the first time. This technology will prove to be extremely important in diseases which affect the brain because of its relative inaccessibility - it's far easier to get a skin sample than a brain biopsy. Once we have neurons from patients we can compare the functioning of cells taken from patients with the disease and those without to better understand why dopamine neurons die in patients with Parkinson's."

Over the next five years, the researchers funded by the charity Parkinson's UK, will combine their stem cell work with the latest techniques in , protein science and brain imaging to develop ways of detecting the early development of Parkinson's disease in individuals before symptoms arrive.

The £5 million Monument Discovery Award given to Dr Wade-Martins and his team is the largest grant ever awarded by Parkinson's UK.

Dr Kieran Breen, Parkinson's UK Director of Research said: "We are passionate about finding a cure for Parkinson's. This is vital research that will help us better understand the causes of this devastating condition and how it develops and progresses. We hope the work will pave the way for new and better treatments for people with Parkinson's in the future."

Related Stories

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

youbo
not rated yet Jul 17, 2010

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.